Redmile Group’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.3M | Sell |
4,872,225
-488,962
| -9% | -$4.55M | 4.82% | 5 |
|
|
2025
Q1 | $36.1M | Buy |
5,361,187
+533,161
| +11% | +$3.59M | 3.41% | 9 |
|
|
2024
Q4 | $51.3M | Sell |
4,828,026
-61,528
| -1% | -$653K | 3.57% | 7 |
|
|
2024
Q3 | $71.5M | Hold |
4,889,554
| – | – | 4.21% | 4 |
|
|
2024
Q2 | $59.2M | Hold |
4,889,554
| – | – | 3.58% | 5 |
|
|
2024
Q1 | $121M | Buy |
4,889,554
+1,010,139
| +26% | +$24.9M | 4.43% | 3 |
|
|
2023
Q4 | $41.5M | Buy |
+3,879,415
| New | +$41.5M | 1.48% | 18 |
|